Coronary Stenosis

Cardiovascular
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pulse Biosciences
Pulse BiosciencesCA - Hayward
1 program
CT-QFRN/A1 trial
Active Trials
NCT04665817UnknownEst. Dec 2022
C
CordisFL - Miami Lakes
1 program
CYPHER® Bx Velocity™ stentN/A1 trial
Active Trials
NCT00403338Completed1,500Est. Apr 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pulse BiosciencesCT-QFR
CordisCYPHER® Bx Velocity™ stent

Clinical Trials (2)

Total enrollment: 1,500 patients across 2 trials

Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study

Start: Oct 2020Est. completion: Dec 2022
N/AUnknown
NCT00403338CordisCYPHER® Bx Velocity™ stent

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Start: Dec 2004Est. completion: Apr 20061,500 patients
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space